查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1553482

转染试剂和仪器市场规模、份额、趋势分析报告：按产品、方法、应用、最终用途、地区和细分市场预测，2024-2030 年

Transfection Reagents & Equipment Market Size, Share & Trends Analysis Report, By Product, By Method (Electroporation), By Application (Transgenic Models), By End-use, By Region, And Segment Forecasts, 2024 - 2030
出版日期: | 出版商: Grand View Research | 英文 100 Pages | 商品交期: 2-10个工作天内

价格
简介目录

转染试剂及设备市场成长及趋势：

Grand View Research, Inc.最新报告显示，到2030年，全球转染试剂和仪器市场规模预计将达到21.9亿美元，2024年至2030年复合年增长率为7.7%。

与阳离子脂质体相比，基于现代聚合物製剂的化合物对细胞友好，并且这些产品实现了更高的基因转移效率，进一步促进了市场上独特转染产品的开发。

此外，多组分试剂（例如 F. Hoffmann-La Roche AG 的 X-tremeGENE）比传统的单组分製剂具有更高的效率和最小的细胞毒性。因此，企业热衷于提供尖端的转染解决方案，这反过来又为市场成长提供了重要动力。

基因表现研究领域在市场上占据主导地位，并在 2019 年占据最大的收益占有率。这是由于临床实践中对基因组资讯翻译的日益关注。此外，与染色体异常识别相关的研究计划数量的增加预计将推动该领域的成长。

转染试剂和设备市场报告亮点

  • 试剂细分市场在转染试剂和设备市场中占据主导地位，2023年销售份额最大，为55.4%。
  • 电穿孔产业在 2023 年占据市场主导地位。从知名公司到新兴公司的各种电穿孔解决方案正在推动该领域的成长。
  • 生物医学研究领域预计在预测期内复合年增长率最快。近年来，利用慢病毒进行转染在生物医学研究中受到广泛关注。
  • 2023年，北美在转染试剂和设备市场中占据最大的销售份额。预计该地区在预测期内将继续这种模式。
  • 市场参与企业热衷于扩大产品系列以维持市场竞争。
  • 例如，2019年7月，Mirus Bio推出了TransIT-VirusGEN SELECT转染试剂，旨在用于基因和细胞製造中的药物发现过程。该材料简化了临床前和早期临床试验的病毒载体製造中使用的辅助材料的鑑定流程。

目录

第一章调查方法与范围

第 2 章执行摘要

第三章转染试剂和设备市场变数、趋势和范围

  • 市场介绍/系统展望
  • 市场规模及成长前景
  • 市场动态
    • 市场驱动因素分析
    • 市场限制因素分析
  • 转染试剂及设备市场分析工具
    • 波特的分析
    • PESTEL分析

第四章 转染试剂与设备市场：依产品估算与趋势分析

  • 细分仪表板
  • 转染试剂和设备市场：2023 年和 2030 年产品变异分析
  • 试剂
  • 装置

第五章转染试剂和设备市场：方法估计和趋势分析

  • 细分仪表板
  • 转染试剂与设备市场：方法变异分析，2023 年和 2030 年
  • 电穿孔
  • 脂质体
  • 粒子撞击
  • 显微注射
  • 腺病毒载体
  • 磷酸钙
  • DEAE-聚葡萄糖
  • 磁珠
  • 活化的树状聚合物
  • 雷射感染

第六章 转染试剂与设备市场：依应用估算与趋势分析

  • 细分仪表板
  • 转染试剂和仪器市场：2023 年和 2030 年应用变化分析
  • 基因表现研究
  • 蛋白质生产
  • 基因改造模型
  • 实施治疗
  • 癌症研究
  • 生物医学研究

第七章 转染试剂和设备市场：依最终用途分类的估算与趋势分析

  • 细分仪表板
  • 转染试剂和设备市场：2023 年和 2030 年最终用途变化分析
  • 学术研究所
  • 製药和生物技术公司

第八章转染试剂和设备市场：区域估计和趋势分析

  • 2023 年和 2030 年按地区分類的转染试剂和设备
  • 北美洲
    • 2018-2030年北美转染试剂和设备市场估计与预测
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 2018-2030年欧洲转染试剂和设备市场估计与预测
    • 英国
    • 德国
    • 义大利
    • 西班牙
    • 丹麦
    • 瑞典
    • 挪威
  • 亚太地区
    • 2018-2030年亚太地区转染试剂和设备市场估计和预测
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 韩国
    • 泰国
  • 拉丁美洲
    • 2018-2030 年拉丁美洲转染试剂和设备市场估计与预测
    • 巴西
    • 阿根廷
  • 中东和非洲
    • 中东和非洲转染试剂和设备市场估计和预测，2018-2030
    • 南非
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 科威特

第9章 竞争格局

  • 主要市场参与企业的最新趋势和影响分析
  • 公司分类
  • 企业热力图分析
  • 公司简介
    • Thermo Fisher Scientific, Inc.
    • Promega Corporation
    • Lonza
    • QIAGEN
    • F. Hoffmann-La Roche Ltd.
    • Bio-Rad Laboratories Inc.
    • Merck KGaA
    • OriGene Technologies Inc
    • MaxCyte, Inc.
    • Polyplus
简介目录
Product Code: 978-1-68038-715-5

Transfection Reagents & Equipment Market Growth & Trends:

The global transfection reagents & equipment market size is expected to reach USD 2.19 billion by 2030, registering a CAGR of 7.7% from 2024 to 2030, according to a new report by Grand View Research, Inc. The latest polymeric formulations-based compounds are gentle to cells as compared to cationic liposomes and these products render higher gene-delivery efficiency, further promoting the development of unique transfection products in the market.

Moreover, multi-component reagents such as X-tremeGENE provided by F. Hoffmann-La Roche AG, deliver high efficiency and minimal cytotoxicity than traditional ones comprising only one-component formulations. Thus, companies are keen on offering cutting-edge transfection solutions, in turn, offering significant momentum to market growth.

The gene expression studies segment dominated the market and account for the largest revenue share in 2019. This is attributed to the rising focus on the translation of genomic information in clinics. In addition, an increasing number of research projects related to the identification of chromosomal anomalies is anticipated to propel segment growth.

Transfection Reagents & Equipment Market Report Highlights:

  • The reagents segment dominated the transfection reagents and equipment market, with the largest revenue share of 55.4% in 2023.
  • The electroporation segment dominated the market in 2023. The broad selection of electroporation solutions from well-known and up-and-coming companies is driving growth in the segment.
  • The biomedical research segment is expected to register the fastest CAGR over the forecast period. In recent times, there has been a significant focus on the use of lentivirus for transfection in biomedical research.
  • North America dominated with largest revenue share in the transfection reagents and equipment market in 2023. The region is expected to continue this pattern in the forecast time frame.
  • Market participants are keen on expanding their product portfolios aimed at sustaining market competition.
  • For instance, in July 2019, Mirus Bio launched TransIT-VirusGEN SELECT Transfection Reagent, intended to be used in the drug discovery process in gene and cell manufacturing. The substance simplifies the qualifying process of ancillary materials employed in viral vectors manufacturing for preclinical and early-phase clinical trials.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Market Definitions
  • 1.3. Research Methodology
    • 1.3.1. Information Procurement
    • 1.3.2. Information or Data Analysis
    • 1.3.3. Market Formulation & Data Visualization
    • 1.3.4. Data Validation & Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1. List of Data Sources

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. Transfection Reagents and Equipment Market Variables, Trends, & Scope

  • 3.1. Market Introduction/Lineage Outlook
  • 3.2. Market Size and Growth Prospects (USD Million)
  • 3.3. Market Dynamics
    • 3.3.1. Market Drivers Analysis
    • 3.3.2. Market Restraints Analysis
  • 3.4. Transfection Reagents and Equipment Market Analysis Tools
    • 3.4.1. Porter's Analysis
      • 3.4.1.1. Bargaining power of the suppliers
      • 3.4.1.2. Bargaining power of the buyers
      • 3.4.1.3. Threats of substitution
      • 3.4.1.4. Threats from new entrants
      • 3.4.1.5. Competitive rivalry
    • 3.4.2. PESTEL Analysis
      • 3.4.2.1. Political landscape
      • 3.4.2.2. Economic and Social landscape
      • 3.4.2.3. Technological landscape
      • 3.4.2.4. Environmental landscape
      • 3.4.2.5. Legal landscape

Chapter 4. Transfection Reagents and Equipment Market: Product Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Transfection Reagents and Equipment Market: Product Movement Analysis, 2023 & 2030 (USD Million)
  • 4.3. Reagents
    • 4.3.1. Reagents Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.4. Equipment
    • 4.4.1. Software Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Transfection Reagents and Equipment Market: Method Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Transfection Reagents and Equipment Market: Method Movement Analysis, 2023 & 2030 (USD Million)
  • 5.3. Electroporation
    • 5.3.1. Electroporation Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.4. Liposomes
    • 5.4.1. Liposomes Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.5. Particle Bombardment
    • 5.5.1. Particle Bombardment Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.6. Microinjection
    • 5.6.1. Microinjection Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.7. Adenoviral Vectors
    • 5.7.1. Adenoviral Vectors Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.8. Calcium Phosphate
    • 5.8.1. Calcium Phosphate Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.9. DEAE-dextran
    • 5.9.1. DEAE-dextran Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.10. Magnetic Beads
    • 5.10.1. Magnetic Beads Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.11. Activated Dendrimers
    • 5.11.1. Activated Dendrimers Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.12. Laserfection
    • 5.12.1. Laserfection Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Transfection Reagents and Equipment Market: Application Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. Transfection Reagents and Equipment Market: Application Movement Analysis, 2023 & 2030 (USD Million)
  • 6.3. Gene Expression Studies
    • 6.3.1. Gene Expression Studies Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.4. Protein Production
    • 6.4.1. Protein Production Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5. Transgenic Models
    • 6.5.1. Transgenic Models Studies Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.6. Therapeutic Delivery
    • 6.6.1. Therapeutic Delivery Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.7. Cancer Research
    • 6.7.1. Cancer Research Studies Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.8. Biomedical Research
    • 6.8.1. Biomedical Research Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Transfection Reagents and Equipment: End Use Estimates & Trend Analysis

  • 7.1. Segment Dashboard
  • 7.2. Transfection Reagents and Equipment Market: End Use Movement Analysis, 2023 & 2030 (USD Million)
  • 7.3. Academic and Research Institutes
    • 7.3.1. Academic and Research Institutes Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.4. Pharmaceutical and Biotechnological Companies
    • 7.4.1. Pharmaceutical and Biotechnological Companies Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 8. Transfection Reagents and Equipment: Regional Estimates & Trend Analysis

  • 8.1. Transfection Reagents and Equipment, By Region, 2023 & 2030 (USD Million)
  • 8.2. North America
    • 8.2.1. North America Transfection Reagents and Equipment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.2.2. U.S.
      • 8.2.2.1. U.S. Transfection Reagents and Equipment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.2.3. Canada
      • 8.2.3.1. Canada Transfection Reagents and Equipment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.2.4. Mexico
      • 8.2.4.1. Mexico Transfection Reagents and Equipment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.3. Europe
    • 8.3.1. Europe Transfection Reagents and Equipment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.3.2. UK
      • 8.3.2.1. UK Transfection Reagents and Equipment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.3.3. Germany
      • 8.3.3.1. Germany Transfection Reagents and Equipment Market Estimates and Forecasts, 2018- 2030 (USD Million)
    • 8.3.4. Italy
      • 8.3.4.1. Italy Transfection Reagents and Equipment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.3.5. Spain
      • 8.3.5.1. Spain Transfection Reagents and Equipment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.3.6. Denmark
      • 8.3.6.1. Denmark Transfection Reagents and Equipment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.3.7. Sweden
      • 8.3.7.1. Sweden Transfection Reagents and Equipment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.3.8. Norway
      • 8.3.8.1. Norway Transfection Reagents and Equipment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.4. Asia Pacific
    • 8.4.1. Asia Pacific Transfection Reagents and Equipment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.4.2. Japan
      • 8.4.2.1. Japan Transfection Reagents and Equipment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.4.3. China
      • 8.4.3.1. China Transfection Reagents and Equipment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.4.4. India
      • 8.4.4.1. India Transfection Reagents and Equipment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.4.5. Australia
      • 8.4.5.1. Australia Transfection Reagents and Equipment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.4.6. South Korea
      • 8.4.6.1. South Korea Transfection Reagents and Equipment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.4.7. Thailand
      • 8.4.7.1. Thailand Transfection Reagents and Equipment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.5. Latin America
    • 8.5.1. Latin America Transfection Reagents and Equipment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.5.2. Brazil
      • 8.5.2.1. Brazil Transfection Reagents and Equipment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.5.3. Argentina
      • 8.5.3.1. Argentina Transfection Reagents and Equipment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.6. Middle East and Africa
    • 8.6.1. Middle East and Africa Transfection Reagents and Equipment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.6.2. South Africa
      • 8.6.2.1. South Africa Transfection Reagents and Equipment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.6.3. Saudi Arabia
      • 8.6.3.1. Saudi Arabia Transfection Reagents and Equipment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.6.4. UAE
      • 8.6.4.1. UAE Transfection Reagents and Equipment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.6.5. Kuwait
      • 8.6.5.1. Kuwait Transfection Reagents and Equipment Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 9. Competitive Landscape

  • 9.1. Recent Developments & Impact Analysis by Key Market Participants
  • 9.2. Company Categorization
  • 9.3. Company Heat Map Analysis
  • 9.4. Company Profiles
    • 9.4.1. Thermo Fisher Scientific, Inc.
      • 9.4.1.1. Participant's Overview
      • 9.4.1.2. Financial Performance
      • 9.4.1.3. Product Benchmarking
      • 9.4.1.4. Recent Developments/ Strategic Initiatives
    • 9.4.2. Promega Corporation
      • 9.4.2.1. Participant's Overview
      • 9.4.2.2. Financial Performance
      • 9.4.2.3. Product Benchmarking
      • 9.4.2.4. Recent Developments/ Strategic Initiatives
    • 9.4.3. Lonza
      • 9.4.3.1. Participant's Overview
      • 9.4.3.2. Financial Performance
      • 9.4.3.3. Product Benchmarking
      • 9.4.3.4. Recent Developments/ Strategic Initiatives
    • 9.4.4. QIAGEN
      • 9.4.4.1. Participant's Overview
      • 9.4.4.2. Financial Performance
      • 9.4.4.3. Product Benchmarking
      • 9.4.4.4. Recent Developments/ Strategic Initiatives
    • 9.4.5. F. Hoffmann-La Roche Ltd.
      • 9.4.5.1. Participant's Overview
      • 9.4.5.2. Financial Performance
      • 9.4.5.3. Product Benchmarking
      • 9.4.5.4. Recent Developments/ Strategic Initiatives
    • 9.4.6. Bio-Rad Laboratories Inc.
      • 9.4.6.1. Participant's Overview
      • 9.4.6.2. Financial Performance
      • 9.4.6.3. Product Benchmarking
      • 9.4.6.4. Recent Developments/ Strategic Initiatives
    • 9.4.7. Merck KGaA
      • 9.4.7.1. Participant's Overview
      • 9.4.7.2. Financial Performance
      • 9.4.7.3. Product Benchmarking
      • 9.4.7.4. Recent Developments/ Strategic Initiatives
    • 9.4.8. OriGene Technologies Inc
      • 9.4.8.1. Participant's Overview
      • 9.4.8.2. Financial Performance
      • 9.4.8.3. Product Benchmarking
      • 9.4.8.4. Recent Developments/ Strategic Initiatives
    • 9.4.9. MaxCyte, Inc.
      • 9.4.9.1. Participant's Overview
      • 9.4.9.2. Financial Performance
      • 9.4.9.3. Product Benchmarking
      • 9.4.9.4. Recent Developments/ Strategic Initiatives
    • 9.4.10. Polyplus
      • 9.4.10.1. Participant's Overview
      • 9.4.10.2. Financial Performance
      • 9.4.10.3. Product Benchmarking
      • 9.4.10.4. Recent Developments/ Strategic Initiatives